Delivery Order SPE2DR25D1200-SPE2DR26FML0B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,472.12 to AmerSourceBergen Drug Corp for the supply of Benlysta 400 mg vials, with an ultimate completion date of February 4, 2026. This is a firm fixed-price contract with no set-aside designation, issued competitively to the prime contractor. The work will be performed at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,973.34 to AmerSourcebergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed-price contract with no set-aside designation, awarded on January 23, 2026, with a completion date of February 13, 2026. The place of performance is Conshohocken, Pennsylvania, where AmerSourcebergen Drug Corp maintains its corporate headquarters. This delivery order represents a task order issued under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $20.9K to AmerSourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injector on January 12, 2026. The contract is firm fixed-price with a completion date of February 3, 2026, and carries no set-aside designation, indicating it was competitively awarded. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order operates as a...
- The Defense Logistics Agency awarded a $3,486.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for the supply of Benlysta 200 mg/ml auto-injector medication, with completion expected by February 24, 2026. This is a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a subsidiary of parent company Cencora, Inc. (which does business as...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of December 30, 2025. This non-competitive delivery order represents a firm fixed price pharmaceutical supply contract fulfilling federal medical procurement needs. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $3,486.67 to AmerSourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. This competitively awarded, firm fixed-price contract was issued on January 20, 2026, with an ultimate completion date of February 10, 2026. The place of performance is AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order execution under a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors, with an ultimate completion date of January 22, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $3,486.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Benlysta 200 mg/ml auto-injectors, with completion scheduled for February 23, 2026. This is a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen) and serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $3,486.67 firm fixed price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical products, with a completion date of January 27, 2026. The award was made on January 5, 2026, with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the place of performance for this order—is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $13,946.68 to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of February 19, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a subsidiary of Cencora, Inc., a major...
- SPE2DR25D1200Indefinite Delivery Contract
- SPE2DR25D1200-SPE2DR26FML0BDelivery Order
The Defense Logistics Agency awarded a $3,486.67 delivery order to AmerSourceBergen Drug Corp on February 2, 2026, for Benlysta 200 mg/ml auto-injector pharmaceutical product, with completion targeted for February 24, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a subsidiary of Cencora, Inc., which serves as the parent organization. The company functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA supply chain. This delivery order falls under the broader pharmaceutical prime vendor program administered by DLA Troop Support, which leverages a $999,999,999.00 indefinite delivery vehicle through December 2026. AmerSourceBergen's contract portfolio demonstrates substantial capability to supply specialty medications, brand-name and generic pharmaceuticals, vaccines, and related medical supplies across multiple therapeutic domains to support military treatment facilities and federal healthcare systems globally. The award reflects the contractor's competitively demonstrated ability to fulfill government pharmaceutical requirements on an open and unrestricted basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 2/1/26 |